Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	INCYIncyte	BNTXBiontech SE	MRNAModerna
Snapshot
Price	$120.45	$93.27	$57.77
Market cap	$23.35B	$24.67B	$31.65B
Valuation
P/E	16.8x	—	—
Forward P/E	12x	—	—
Growth
Revenue growth	21.5%	-11.8%	-30.0%
EPS growth	2455.3%	—	—
Profitability
Net margin	26.7%	-34.0%	-143.6%
ROE	29.2%	-6.7%	-36.7%
Balance sheet & cash
Debt / equity	0.01x	0.01x	0.07x
Free cash flow yield	2.2%	13.6%	-13.6%
Dividend yield	—	—	—
Verdict
Investment rating	Strong· 86	Weak· 31	Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	INCYtoday $120	BNTXtoday $93	MRNAtoday $58
2027	$2,308.40 – $3,385.66+2711% CAGR	$71.35 – $104.65+12% CAGR	$44.19 – $64.82+12% CAGR
2028	$58,986.86 – $86,514.06+2580% CAGR	$72.78 – $106.74+7% CAGR	$45.08 – $66.11+7% CAGR
2029	$1,507,297.06 – $2,210,702.35+2538% CAGR	$74.23 – $108.88+5% CAGR	$45.98 – $67.44+5% CAGR
2030	$38,516,112.44 – $56,490,298.25+2517% CAGR	$75.72 – $111.05+4% CAGR	$46.90 – $68.79+4% CAGR
2031	$984,206,072.81 – $1,443,502,240.12+2504% CAGR	$77.23 – $113.28+4% CAGR	$47.84 – $70.16+4% CAGR
5-yr CAGR	2312.4% – 2504.5%	-3.7% – 4.0%	-3.7% – 4.0%